Silver Spring, MD, United States of America

Christopher C Broder

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 87(Granted Patents)


Location History:

  • Rockville, MD (US) (1993 - 2012)
  • Silver Springs, MD (US) (2019)
  • Silver Spring, MD (US) (2011 - 2022)

Company Filing History:


Years Active: 1993-2022

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Christopher C. Broder: Innovator in Viral Research and Antibody Development

Introduction

Christopher C. Broder, based in Silver Spring, MD, is a notable inventor with a significant portfolio, holding a total of 25 patents. His contributions primarily lie in the fields of viral research and antibody development, where his inventions aim to address infectious diseases.

Latest Patents

Among his most recent innovations are two pivotal patents. The first, titled "Antibodies against F glycoprotein of Hendra and Nipah viruses," centers on antibodies or antibody fragments that effectively bind, neutralize, and inhibit the Hendra and Nipah viruses. This invention not only provides a strategic approach to combat these viral threats but also includes pharmaceutical compositions featuring the antibodies this invention entails. Furthermore, it offers polynucleotides that encode these antibodies and fragments, alongside host cells that have been transformed with the relevant materials. The second recent patent focuses on "Immunogenic Cedar Virus compositions," which details a novel virus known as Cedar Virus and the methods for its utilization.

Career Highlights

Christopher has spent considerable time at esteemed organizations, including the Henry M. Jackson Foundation for the Advancement of Military Medicine and the United States Department of Health and Human Services. His work in these institutions has bolstered his innovative capacity and facilitated significant advancements in the field of medical science.

Collaborations

Throughout his career, Broder has collaborated with prominent colleagues such as Katharine Bossart and Yee-Peng Chan. These partnerships have further enhanced the depth and impact of his research, leading to groundbreaking developments in the field.

Conclusion

Christopher C. Broder exemplifies a dedicated innovator making strides in viral research and antibody development. With substantial patents to his name and valuable collaborations, his work continues to push the boundaries of medical science and contributes to public health advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…